Cargando…
Nebulised heparin: a new approach to the treatment of acute lung injury?
The administration of heparin by nebulisation has been proposed for the 'local' treatment of pulmonary coagulation disturbances in acute lung injury (ALI). Alveolar and lung micro-vascular fibrin accumulation and breakdown inhibition indeed play a central role in the development and clinic...
Autor principal: | Suter, Peter M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575564/ https://www.ncbi.nlm.nih.gov/pubmed/18671836 http://dx.doi.org/10.1186/cc6947 |
Ejemplares similares
-
A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008) -
Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021) -
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020) -
Reducing ventilator-induced lung injury and other organ injury by the prone position
por: Suter, Peter M
Publicado: (2006) -
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study()
por: DeNucci, Gilberto, et al.
Publicado: (2023)